1719 Episodes

  1. Three-Year Outcomes after Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients with Aortic Stenosis

    Published: 4/24/2023

  2. Three-Year Outcomes after Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients with Aortic Stenosis

    Published: 4/24/2023

  3. JACC - May 2, 2023 Issue Summary

    Published: 4/24/2023

  4. Lipoprotein(a) Lowering Therapies: Considerations for Clinical Trial Design for Atherosclerotic Cardiovascular Disease Risk Reduction

    Published: 4/17/2023

  5. Lipoprotein(a) Lowering Therapies: Considerations for Clinical Trial Design for Atherosclerotic Cardiovascular Disease Risk Reduction

    Published: 4/17/2023

  6. Triglyceride Rich Lipoprotein Lowering Therapies: Considerations for Clinical Trial Design Targeting Atherosclerotic Cardiovascular Disease

    Published: 4/17/2023

  7. Triglyceride Rich Lipoprotein Lowering Therapies: Considerations for Clinical Trial Design Targeting Atherosclerotic Cardiovascular Disease

    Published: 4/17/2023

  8. Familial Hypercholesterolemia: Challenges for a High-Risk Population

    Published: 4/17/2023

  9. Familial Hypercholesterolemia: Challenges for a High-Risk Population

    Published: 4/17/2023

  10. Long-Term Healthcare Utilization after Cardiac Surgery in Children Covered under Medicaid

    Published: 4/17/2023

  11. Exercise Capacity, NT-pro BNP and Exercise Hemodynamics in Adults Post-Fontan

    Published: 4/17/2023

  12. Long-Term Healthcare Utilization after Cardiac Surgery in Children Covered under Medicaid

    Published: 4/17/2023

  13. Exercise Capacity, NT-pro BNP and Exercise Hemodynamics in Adults Post-Fontan

    Published: 4/17/2023

  14. The clinical and prognostic relevance of cardiac wasting in patients with advanced cancer:A prospective study.

    Published: 4/17/2023

  15. The clinical and prognostic relevance of cardiac wasting in patients with advanced cancer:A prospective study.

    Published: 4/17/2023

  16. Efficacy and safety of the oral PCSK9 inhibitor MK-0616: a phase 2b randomized controlled trial

    Published: 4/17/2023

  17. Efficacy and safety of the oral PCSK9 inhibitor MK-0616: a phase 2b randomized controlled trial

    Published: 4/17/2023

  18. JACC - April 25, 2023 Issue Summary

    Published: 4/17/2023

  19. JACC - April 25, 2023 Issue Summary

    Published: 4/17/2023

  20. Evolving Science on Cardiovascular Disease among Hispanic/Latino Adults: JACC International

    Published: 4/10/2023

39 / 86

Each week, Valentin Fuster, MD, PhD, MACC, records free podcasts highlighting journal findings. To keep clinicians updated on the most important science emerging in clinical and translational cardiology, Dr. Fuster provides an overview of the weekly edition from the Journal of the American College of Cardiology (JACC), as well as a short summary of each manuscript. Encompassing JACC and nine cardiovascular specialty journals, the JACC family of journals rank among the top cardiovascular peer-reviewed journals in the world for scientific impact.